Metropolis Healthcare rallied 4.83% to Rs 1,819.20 after the company reported 15.4% increase in consolidated net profit to Rs 31.36 crore in Q3 FY25 as against Rs 27.16 crore posted in Q3 FY24.

India’s second-largest pathology laboratory chain, Metropolis Healthcare, posted a 15.5 per cent year-on-year (Y-o-Y) growth ...

Metropolis collaborates with Roche Diagnostics India to introduce self-sampling HPV DNA test for early detection of cervical cancer: Our Bureau, Bengaluru Monday, February 3, 2025 ...

Union Budget 2025-26 allocates ₹98,311 crore for the healthcare sector, signaling a significant push for growth, with key measures like customs duty exemptions on life-saving drugs and the ...

Expect demand for early and precise diagnostics to surge due to expansion of telemedicine infrastructure through broadband ...

India presents a huge opportunity for the diagnostics sector but the lack of minimum standards and weak practices are ...